USANA Health Sciences, Inc. (NYSE:USNA) Q4 2023 Earnings Call Transcript

There’s understanding between both sides. And I think as long as you’re complying within the regulatory framework that’s been outlaid, I think we have no reason to be nothing but optimistic about the future that we can continue to grow and develop our business there.

Doug Lane : And you’re back to holding meetings at the same pace pre-COVID or the same magnitude pre-COVID in China?

Brent Neidig : Yes. We have returned to our meeting cadence and size. That was severely restricted during the COVID era. But now in April, we have our China convention that’s coming up, and that is actually going to be held in Mainland China. We haven’t done that in several years. We’ve had a very large response to that. So we’re very optimistic about that event. And we’ll continue to hold events at a very regular cadence throughout the year.

Operator: As we have no further questions, I would like to turn it back over to Andrew Masuda for any closing remarks.

Andrew Masuda: Thank you for your questions and for your participation on today’s conference call. If you have any remaining questions, please feel free to contact Investor Relations at (801) 954-7210. Thank you very much.

Operator: That concludes today’s conference. You may now disconnect. Hosts, you may stay on the line.